Recent Press Releases

Sarepta Enters into Partnership with Flagship Biosciences to Digitally Automate the Measurement of Dystrophin, a Key Therapeutic Efficacy Marker for Muscular Dystrophy

Sarepta Enters into Partnership with Flagship Biosciences to Digitally Automate the Measurement of Dystrophin, a Key Therapeutic Efficacy Marker for Muscular Dystrophy New technology designed to...

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology SAN DIEGO--(BUSINESS WIRE)--Aug. 21, 2014-- Illumina, Inc. (NASDAQ:ILMN)...

LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test August 19, 2014 08:45 AM Eastern Daylight Time

LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test August 19, 2014 08:45 AM Eastern Daylight Time BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America®...

MDxHealth ConfirmMDx Biomarker Associated with the Risk of Recurrence for Early Stage Prostate Cancer Patients

MDxHealth ConfirmMDx Biomarker Associated with the Risk of Recurrence for Early Stage Prostate Cancer Patients Validation Study Data Published in The Journal of Urology® IRVINE, California, and...

Cancer Genetics Reports Second Quarter 2014 Financial Results

Cancer Genetics Reports Second Quarter 2014 Financial Results Conference Call Today at 8:30 a.m. Eastern / 5:30 a.m. Pacific 0 0 0 0 August 14, 2014 07:05 ET | Source:...

Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy

Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy Early, more accurate detection of this potentially deadly fungus can improve patient outcomes, according to new...

Biocept Provides Second Quarter Operational Update

Biocept Provides Second Quarter Operational Update SAN DIEGO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor...

Protagen AG Launches Landmark First Research Test Kit for Systemic Scleros

Dortmund, Germany – 13th August, 2014. Protagen AG, a company dedicated to the development of powerful diagnostic tools to address some of the most severe autoimmune diseases, has today...

Castle Biosciences Announces $11.8 Million Financing Led by New Investor HealthQuest Capital

Castle Biosciences Announces $11.8 Million Financing Led by New Investor HealthQuest Capital Funds to Expand Clinical Availability of Cutaneous Melanoma Gene Expression Profile Test Friendswood, TX...

Seventh Sense Biosystems Closes $16 Million Series B Financing

Seventh Sense Biosystems Closes $16 Million Series B Financing New Investors Siemens, Novartis and LabCorp® Join Polaris Partners and Flagship Ventures to Fund Development and Launch of Patented...

FDA approves first non-invasive DNA screening test for colorectal cancer

FDA approves first non-invasive DNA screening test for colorectal cancer Collaboration with CMS contributed to proposed Medicare coverage The U.S. Food and Drug Administration today approved...

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Tes

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test First time in history a technology receives FDA approval and proposed national...

Epigenomics AG Announces H1 2014 and Q2 2014 Financial Results and Reports on Operational Highlights

Epigenomics AG Announces H1 2014 and Q2 2014 Financial Results and Reports on Operational Highlights Berlin (Germany) and Germantown, MD (U.S.A.), August 12, 2014 - Epigenomics AG (Frankfurt Prime...

Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy

Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy Quest Diagnostics and GE Healthcare Veteran Amy McNeal Brings Experience to Biocept Team August 06, 2014 08:30 ET |...

Oxford Immunotec Reports Second Quarter 2014 Financial Results

Oxford Immunotec Reports Second Quarter 2014 Financial Results 2014 Second Quarter Revenue of $11.8 Million Increased 16% Compared to Prior Year Net Loss was $6.2 Million for the Second Quarter ...

Oxford Immunotec Announces Purchase of Assets of Boulder Diagnostics Inc.

Oxford Immunotec Announces Purchase of Assets of Boulder Diagnostics Inc. OXFORD, United Kingdom and MARLBOROUGH, Mass., August 5, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (NASDAQ:...

Exosome Diagnostics Announces Appointment of Thomas McLain as Chief Executive Officer -Company moves headquarters to Cambridge, Mass. -

Exosome Diagnostics Announces Appointment of Thomas McLain as Chief Executive Officer -Company moves headquarters to Cambridge, Mass. - CAMBRIDGE, Mass., Aug. 4, 2014 /PRNewswire/ -- Exosome...

AdvaMedDx Commends FDA's Issuance of LDT Draft Framework

AdvaMedDx Commends FDA's Issuance of LDT Draft Framework July 31, 2014 WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding FDA's...

ACLA Expresses Concern with FDA Guidance on Laboratory Developed Tests (LDTs)

ACLA Expresses Concern with FDA Guidance on Laboratory Developed Tests (LDTs) July 31, 2014 WASHINGTON, DC – In response to today's announcement that the Food and Drug Administration (FDA)...

The Association for Molecular Pathology Voices Concern with U.S. FDA Anticipated Details of Laboratory Developed Test Draft Guidance

The Association for Molecular Pathology Voices Concern with U.S. FDA Anticipated Details of Laboratory Developed Test Draft Guidance Reaffirms Position that Current CLIA Program at the Centers for...